Table S4.
Univariate Cox proportional hazards regression analyses for DSS
| Variables | No. of patients | HR | 95% CI | P-value |
|---|---|---|---|---|
| Age (years) (≥54 vs <54) | 114 | 1.018 | 0.530–1.958 | 0.957 |
| Phimosis (yes vs no) | 114 | 0.914 | 0.646–1.293 | 0.613 |
| T stage (T2–4 vs T1/a) | 114 | 2.772 | 1.153–6.663 | 0.023* |
| Pathology grade (G2–3 vs G1) | 114 | 4.055 | 2.023–8.125 | <0.001** |
| N stage (N+ vs N0/X) | 114 | 7.628 | 3.461–16.814 | <0.001** |
| SCC-Ag (ng/mL) (≥1.5 vs < 1.5) | 93 | 2.269 | 1.087–4.737 | 0.029* |
| CRP (mg/mL) (≥5.0 vs <5.0) | 79 | 2.465 | 1.064–5.712 | 0.035* |
| sLAMC2 (ng/mL) (≥108 vs <108) | 114 | 6.370 | 3.064–13.242 | <0.001** |
| tLAMC2 (>30% vs ≤30%) | 114 | 2.185 | 1.105–4.319 | 0.025* |
Notes:
*
P<0.05,
**
P<0.01.
Abbreviations: CRP, C-reactive protein; DSS, disease-special survival; LAMC2, laminin gamma 2; SCC-Ag, squamous cell carcinoma antigen; sLAMC2, serum LAMC2 level; tLAMC2, tissue LAMC2 level.